Effect of prostaglandin analogues on anterior scleral thickness and corneal thickness in patients with primary open-angle glaucoma
Abstract Prostaglandin (PG) analogues are usually prescribed as a first-line therapy in patients with glaucoma because of its once-daily dosing benefit and effective intraocular pressure (IOP) reduction. However, the mechanism of PG analogues is not completely understood. In this study, we investiga...
Main Authors: | Ji-Hye Park, Chungkwon Yoo, Hyun Woo Chung, Yong Yeon Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-05-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-90696-4 |
Similar Items
-
Decreased keratocyte density and central corneal thickness in primary open-angle glaucoma patients undergoing treatment with topical prostaglandin analogues
by: Sibel Kocabeyoglu, et al.
Published: (2015-01-01) -
Central corneal thickness in primary angle closure and open angle glaucoma
by: Sasan Moghimi, et al.
Published: (2014-01-01) -
Effect of Topical Prostaglandin Analogue Therapy on Central Corneal Thickness: A Systematic Review
by: Jae-Yun Kim, et al.
Published: (2022-12-01) -
Prostaglandin analogues in angle closure glaucoma
by: Pulkit Gupta, et al.
Published: (2011-01-01) -
Central corneal thickness, corneal curvature and refractive error in patients with primary angle-closure glaucoma and primary open-angle glaucoma
by: Marić V., et al.
Published: (2015-01-01)